Company intelligence / Profile preview

Hana Pharm

Seoul (Gangnam-gu), Seoul, South Korea

Ownership: Private
Employees: ~435
Development stage: Other

Overview

Hana Pharm is a leading Korean pharmaceutical manufacturer with commercialized lines in anesthetics, narcotic analgesics, cardiovascular, gastrointestinal, antiemetic, and musculoskeletal medicines. It develops APIs and produces finished products under GMP, including transdermal patches and injectables. Notable recent clinical achievement includes Phase 3 and launch of remimazolam anesthesia in Korea.

Therapeutic areas: CardiovascularEndocrinologyGastroenterologyNeurologyInfectious DiseasesOtherPsychiatryOncology
Modalities: Small moleculePeptidesTransdermal patchInjectionTabletCapsuleInhalation solution
Industry: Biotech

Drug pipeline

6 assets

Sevofran

5 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Hana Pharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hana Pharm.

Explore the full profile